BioSpace News Archive

Signify Health has announced the launch of Signify Community, the first and only social determinants of health solution that ties social interventions to quality, satisfaction, and financial outcomes—including 30% reductions in readmissions and 46% reductions in post-acute care spend for high-utilizer safety net populations.

Thermo Fisher Scientific Inc., the world leader in serving science, announced that it will release its financial results for the second quarter of 2019 before the market opens on Wednesday, July 24, 2019, and will hold a conference call on the same day at 8:30 a.m. EDT.

Craneware (AIM: CRW.L), the healthcare market leader in automated value cycle solutions, today announced it will be joining Moffitt Cancer Center at the HFMA Annual Conference 2019 to discuss how the organizations are partnering to gain an understanding of AI, and its application to charge capture and denials management

Agilent Technologies Inc. (NYSE: A) today introduced its first new product from recently acquired ACEA Biosciences, at the 34th Congress of the International Society for Advancement of Cytometry, CYTO 2019 Congress, being held June 22–26, 2019 in Vancouver, Canada

NantKwest Inc. (Nasdaq:NK), today announced that the company’s PD-L1 t-haNK investigational new drug application (IND) has cleared FDA review and the program has now transitioned to a first-in-human clinical trial in patients with locally advanced or metastatic solid cancers

ETCH biotrace to Combine Applied DNA’s DNA tag-based Forensic Traceability and Authenticity with TruTrace’s Industry Blockchain Hub to Deliver Unparalleled Tag-Test-Track Capabilities to Global Cannabis and Hemp Industry

China Jo-Jo Drugstores, Inc., a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a healthcare provider in China, announced that the Company has entered into a strategic cooperation framework agreement with the Zhejiang Medical Insurance Bureau in June 2019.

Cerapedics, a privately-held orthobiologics company, today announced the appointment of Patrick O’Connor as Vice President of Clinical and Market Development.

Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer’s disease (AD), announced that Dr. Charles S. Ryan, CEO, will be a featured presenter at the Maxim Group Key Opinion Leader Discussion “Alzheimer’s disease – What’s Next? Treating Alzheimer’s in a Post-Amyloid World,” on Wednesday, June 26th, 2019 at Maxim Group in New York City, NY.

Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”, the “Company”, “we”, “our”, or “us”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and metastatic cancer, announced today that Propanc has appointed Mr. Carlo Campiciano as its Chief Financial Officer, commencing July 1, 2019.